Keros Therapeutics, Inc. - Common Stock (KROS)

CUSIP: 492327101

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
30,507,667
Total 13F shares
35,922,272
Share change
+3,184,122
Total reported value
$479,567,957
Put/Call ratio
116%
Price per share
$13.35
Number of holders
134
Value change
+$53,894,426
Number of buys
83
Number of sells
75

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 492327101?
CUSIP 492327101 identifies KROS - Keros Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Keros Therapeutics, Inc. - Common Stock (KROS) as of Q2 2025

As of 30 Jun 2025, Keros Therapeutics, Inc. - Common Stock (KROS) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,922,272 shares. The largest 10 holders included ADAR1 Capital Management, LLC, BlackRock, Inc., Madison Avenue Partners, LP, VANGUARD GROUP INC, Logos Global Management LP, Nantahala Capital Management, LLC, Western Standard LLC, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, and D. E. Shaw & Co., Inc.. This page lists 134 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
154
Q2 2025 holders
134
Holder diff
-20
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.